Cargando…

Embodying a New Meaning of Being At Risk: Living With an Implantable Cardioverter Defibrillator for Arrhythmogenic Right Ventricular Cardiomyopathy

Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia (ARVC/D) is a genetic condition that can cause fatal arrhythmias. The implantable cardioverter defibrillation (ICD) is a primary treatment for ARVC/D. Using a grounded theory approach, this study examines the experiences of 15 individuals liv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Manuel, April, Brunger, Fern
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342860/ https://www.ncbi.nlm.nih.gov/pubmed/28462346 http://dx.doi.org/10.1177/2333393616674810

Ejemplares similares

Appropriate and Inappropriate Implantable Cardioverter Defibrillators Therapies in Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia Patients
por: Al-Ghamdi, Bandar, et al.
Publicado: (2018)

Comparing clinical performance of current implantable cardioverter-defibrillator implantation recommendations in arrhythmogenic right ventricular cardiomyopathy
por: Bosman, Laurens P, et al.
Publicado: (2021)

Subcutaneous Implantable Cardioverter‐Defibrillator in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: A Transatlantic Experience
por: Orgeron, Gabriela M., et al.
Publicado: (2018)

Comparison of different prediction models for the indication of implanted cardioverter defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy
por: Aquaro, Giovanni Donato, et al.
Publicado: (2020)

Implantable Cardioverter‐Defibrillator Therapy in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy: Predictors of Appropriate Therapy, Outcomes, and Complications
por: Orgeron, Gabriela M., et al.
Publicado: (2017)

Anesthetic management in a patient with arrhythmogenic right ventricular cardiomyopathy and an implantable cardioverter defibrillator: a case report
por: Ohyama, Yoko, et al.
Publicado: (2020)

Transvenous implantable cardioverter-defibrillator implantation in a patient with arrhythmogenic cardiomyopathy and massive right atrial thrombus
por: Hayashi, Hiroshi, et al.
Publicado: (2020)

Usefulness of lead repositioning to improve subcutaneous electrocardiogram sensing in patients with arrhythmogenic right ventricular cardiomyopathy with subcutaneous implantable cardioverter-defibrillator
por: Sasaki, Shingo, et al.
Publicado: (2020)

Additional left ventricular septal lead facilitates R-wave sensing of implantable cardioverter-defibrillator in arrhythmogenic right ventricular cardiomyopathy: a case report
por: Lu, Wenzhao, et al.
Publicado: (2023)

Right Ventricular Thrombosis in a Patient with Arrhythmogenic Right Ventricular Cardiomyopathy Precluding Intracardiac Defibrillator Implantation Initially
por: Bozorgi, Ali, et al.
Publicado: (2021)

Arrhythmogenicity of anti-tachycardia pacing in patients with implantable cardioverter defibrillator
por: Awad, Sherien Samy, et al.
Publicado: (2023)

Implantable cardioverter–defibrillator in hypertrophic cardiomyopathy
por: Sanchez, Diego Jimenez, et al.
Publicado: (2018)

Right ventricular function is a predictor for sustained ventricular tachycardia requiring anti-tachycardic pacing in arrhythmogenic ventricular cardiomyopathy: insight into transvenous vs. subcutaneous implantable cardioverter defibrillator insertion
por: Honarbakhsh, Shohreh, et al.
Publicado: (2023)

Trends in implantable cardioverter defibrillator and cardiac resynchronisation therapy lead parameters for patients with arrhythmogenic and dilated cardiomyopathies
por: Lane, Jem D., et al.
Publicado: (2018)

Arrhythmogenic right ventricular cardiomyopathy
por: Cho, Yongkeun
Publicado: (2018)

Arrhythmogenic Right Ventricular Cardiomyopathy
por: Dolkar, Tsering, et al.
Publicado: (2022)

Higher defibrillation threshold in methamphetamine cardiomyopathy patients with implantable cardioverter-defibrillator
por: Malhotra, Rakesh, et al.
Publicado: (2017)

Role of Implantable Cardioverter Defibrillators in the Treatment of Hypertrophic Cardiomyopathy
por: Ghosh, Joydeep, et al.
Publicado: (2005)

Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia
por: Indik, Julia H, et al.
Publicado: (2003)

Arrhythmogenic right ventricular cardiomyopathy/dysplasia
por: Thiene, Gaetano, et al.
Publicado: (2007)

Focus on arrhythmogenic right ventricular cardiomyopathy
por: Sinagra, Gianfranco, et al.
Publicado: (2020)

Delayed right ventricular perforation complicated by intracardiac thrombosis after implantable cardioverter‐defibrillator implantation
por: Ito, Tsuyoshi, et al.
Publicado: (2017)

A sustained ventricular tachycardia overlooked by subcutaneous implantable cardioverter-defibrillator but recognized by co-implanted transvenous implantable cardioverter defibrillator
por: Goto, Kentaro, et al.
Publicado: (2020)

Survival Following Implantable Cardioverter‐Defibrillator Implantation in Patients With Amyloid Cardiomyopathy
por: Higgins, Angela Y., et al.
Publicado: (2020)

Arrhythmic risk prediction in arrhythmogenic right ventricular cardiomyopathy: external validation of the arrhythmogenic right ventricular cardiomyopathy risk calculator( )
por: Jordà, Paloma, et al.
Publicado: (2022)

Implantable cardioverter-defibrillators /
Publicado: (1994)

Myocardial Scar Characterization and Future Ventricular Arrhythmia in Patients With Ischemic Cardiomyopathy and an Implantable Cardioverter-Defibrillator
por: Noordman, Alwin B. P., et al.
Publicado: (2021)

Predictors of Implantable Cardioverter-Defibrillator Use in Patients with Ischemic Cardiomyopathy
por: Kelly, Ryan, et al.
Publicado: (2010)

Implantable cardioverter-defibrillators in non-ischaemic cardiomyopathy: a need or not?
por: de Groot, Joris R.
Publicado: (2023)

Incidence, Predictors and Clinical Impact of Ventricular Electrical Storm in Arrhythmogenic Cardiomyopathy Patients with an Implantable Cardioverter–Defibrillator: A Single-Center Report with Medium-Term Follow-Up
por: Zhai, Lin, et al.
Publicado: (2021)

Genetic bases of arrhythmogenic right ventricular Cardiomyopathy
por: RAMPAZZO, ALESSANDRA
Publicado: (2006)

Mouse Models in Arrhythmogenic Right Ventricular Cardiomyopathy
por: Lodder, Elisabeth M., et al.
Publicado: (2012)

Desmin Mutations and Arrhythmogenic Right Ventricular Cardiomyopathy
por: Lorenzon, Alessandra, et al.
Publicado: (2013)

Arrhythmogenic right ventricular cardiomyopathy: Electroarchitecture of the substrate
por: Watanabe, Atsuyuki, et al.
Publicado: (2015)

The genetic background of arrhythmogenic right ventricular cardiomyopathy
por: Ohno, Seiko
Publicado: (2016)

Risk Stratification in Arrhythmogenic Right Ventricular Cardiomyopathy
por: Wallace, Ryan, et al.
Publicado: (2021)

Implantable cardioverter defibrillator implantation and degree of left ventricular scarring predict survival in patients with severe ischemic cardiomyopathy
por: Kwon, Deboarh H, et al.
Publicado: (2011)

Incidence of appropriate cardioverter-defibrillator shocks and mortality in patients with implantable cardioverter-defibrillators with ischemic cardiomyopathy versus nonischemic cardiomyopathy at 33-month follow-up
por: Gandhi, Kaushang, et al.
Publicado: (2010)

Significance of intraoperative testing in right-sided implantable cardioverter-defibrillators
por: Keyser, Andreas, et al.
Publicado: (2013)

Implantable cardioverter-defibrillator shocks and nonsustained rapid ventricular rhythms
por: Witteveen, H., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_f5ollv2dlhlt39emg8rc8ahr90